Reason for request
Inclusion
Clinical Benefit
| Moderate |
Moderate AB pending re-assessment of oral antihistamines. |
Clinical Added Value
| no clinical added value |
No improvement in actual benefit (IAB V) compared with other oral H1 antihistamines available in oral form. |
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
zbPsADmKbY46Rg1y
Listen
